ticker stringlengths 1 10 | date timestamp[ns] | client stringlengths 1 80 | client_description stringlengths 2 114 ⌀ | spend float64 0 25.9M | transaction_type stringclasses 7
values | filing_type stringclasses 7
values | lobby_description listlengths 0 34 | issue_codes listlengths 1 34 ⌀ | government_entity_details listlengths 1 725 ⌀ | quarter stringclasses 66
values | effective_date stringlengths 10 10 | termination_date stringlengths 10 10 ⌀ | client_state stringclasses 56
values | client_country stringclasses 40
values | client_id int64 12 10M | government_lobby float64 0 1 ⌀ | performing_own_lobbying float64 0 1 ⌀ | registrant_dt_updated stringlengths 32 32 | registrant_name stringlengths 3 99 | registrant_address stringlengths 32 87 | registrant_id int64 33 401M | registrant_description stringlengths 2 103 ⌀ | registrant_contact_name stringlengths 0 34 | registrant_house_registrant_id float64 12.7k 401M ⌀ | registrant_contact_telephone stringlengths 0 16 | lobbyist_full_names listlengths 1 272 ⌀ | lobbyist_ids listlengths 1 272 ⌀ | previous_goverment_positions listlengths 1 272 ⌀ | lobbyist_new_statuses listlengths 1 272 ⌀ | client_url stringlengths 44 45 | registrant_url stringlengths 45 52 | filing_url stringlengths 88 88 | filing_id stringlengths 36 36 | unique_id stringlengths 46 53 | match stringlengths 1 80 | date_time timestamp[ns] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YNCHF | 2017-10-20T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"- Issues related to Medicare Part B (HOPPS) and Part D \n- Provisions related to repeal of the Independent Payment Advisory Board (IPAB)",
"- FDA Reauthorization Act (H.R. 2430/S. 934)\n- Issues related to the Bayh-Dole Act (Pub. L. 96-517)\n- Issues related to drug pricing and value\n- Issues related to the imp... | [
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q3 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY"
] | [
56477,
64580,
64580,
56477
] | [
null,
null,
null,
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/6d0a6398-7859-4ff9-ac11-cef59e701552/print/ | 6d0a6398-7859-4ff9-ac11-cef59e701552 | 6d0a6398-7859-4ff9-ac11-cef59e701552_400762305_195037 | astellas pharma us, inc. | 2017-10-20T18:27:07 |
YNCHF | 2017-11-13T00:00:00 | astellas pharma us, inc. | Pharmacuetical company. | 60,000 | lobbying_income | modify_service | [
"Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights un... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2016-Q3 | 2009-04-01 | null | DC | US | 1,005,002 | 0 | 0 | 2024-01-02T11:27:52.004862-05:00 | TIBER CREEK GROUP | 750 9th Street NW, Suite 501, Washington, DC, 20001, US | 20,744 | Government Relations. | GRACE BAUM | 31,587 | +1 202-381-6896 | [
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON"
] | [
47178,
26450,
6542
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/127151/ | https://lda.senate.gov/api/v1/registrants/20744/ | https://lda.senate.gov/filings/public/filing/d553e3b7-9fa6-4371-b296-3c5805233c39/print/ | d553e3b7-9fa6-4371-b296-3c5805233c39 | d553e3b7-9fa6-4371-b296-3c5805233c39_20744_127151 | astellas pharma us, inc. | 2017-11-13T17:49:10 |
YNCHF | 2017-12-15T00:00:00 | astellas pharma us, inc. | null | 570,000 | a | modify_service | [
"Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment; comprehensive tax reform.",
"Issues related to oral chemotherapy in The Cancer Drug ... | [
"TAX - Taxation/Internal Revenue Code",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q2 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"MELISSA WIER BANASHAK",
"SARAH CHRISTINE D'ORSIE",
"MARY LACEY REUTHER",
"MELISSA WIER BANASHAK",
"SARAH CHRISTINE D'ORSIE",
"MARY LACEY REUTHER",
"MELISSA WIER BANASHAK",
"SARAH CHRISTINE D'ORSIE"
] | [
54800,
59772,
64567,
54800,
59772,
64567,
54800,
59772,
64567
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/11fca9d8-868d-48bb-9ba7-a2ea3050c9ac/print/ | 11fca9d8-868d-48bb-9ba7-a2ea3050c9ac | 11fca9d8-868d-48bb-9ba7-a2ea3050c9ac_40032268_188248 | astellas pharma us, inc. | 2017-12-15T00:20:22 |
YNCHF | 2018-01-01T00:00:00 | astellas pharma us | Pharmaceutical company | 75,000 | lobbying_income | modify_service | [
"REIMBURSEMENT ISSUES",
"PHARMACEUTICAL AND LIFE SCIENCES ISSUES"
] | [
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] | [
"136 - Centers For Medicare and Medicaid Services (CMS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"136 - Centers For Medicare and Medicaid Services (CMS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2009-Q1 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)",
"JODIE LOCKHART",
"JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)",
"JEFFREY J KIMBELL",
"AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)",
"JODIE LOCKHART",
"JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANT... | [
42442,
35755,
51434,
39999,
42442,
35755,
51434,
39999
] | [
null,
"POLICY ADVISOR, SEN. ENSIGN & BRYAN",
null,
"POLICY ADVISOR, SEN. RICK SANTORUM",
null,
"POLICY ADVISOR, SEN. ENSIGN & BRYAN",
null,
"POLICY ADVISOR, SEN. RICK SANTORUM"
] | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/744ab56c-688a-46d0-9424-5368692e0fb8/print/ | 744ab56c-688a-46d0-9424-5368692e0fb8 | 744ab56c-688a-46d0-9424-5368692e0fb8_46038_153900 | astellas pharma us | null |
YNCHF | 2018-01-01T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"PHARMACEUTICAL AND LIFE SCIENCE ISSUES",
"REIMBURSEMENT ISSUES"
] | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"136 - Centers For Medicare and Medicaid Services (CMS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"136 - Centers For Medicare and Medicaid Services (CMS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2009-Q4 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)",
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)"
] | [
42442,
51434,
39999,
42442,
51434,
39999
] | [
null,
null,
"POLICY ADVISOR, SEN. RICK SANTORUM",
null,
null,
"POLICY ADVISOR, SEN. RICK SANTORUM"
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/883f0264-3369-4cf8-82f8-3e4b861ca463/print/ | 883f0264-3369-4cf8-82f8-3e4b861ca463 | 883f0264-3369-4cf8-82f8-3e4b861ca463_46038_153900 | astellas pharma us | null |
YNCHF | 2018-01-01T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2016-Q4 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"KENNETH LEE HODGE",
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)"
] | [
139878,
42442,
51434,
60159
] | [
null,
null,
null,
"Legislative Director, Rep. Marsha Blackburn"
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/cecd4853-524d-45b2-a32c-26cadc8f53d6/print/ | cecd4853-524d-45b2-a32c-26cadc8f53d6 | cecd4853-524d-45b2-a32c-26cadc8f53d6_46038_153900 | astellas pharma us | null |
YNCHF | 2018-01-12T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"S.1519 - National Defense Authorization Act for Fiscal Year 2018",
"Tax Reform",
"Issues related to pharmaceutical pricing and NIH March In Rights"
] | [
"DEF - Defense",
"TAX - Taxation/Internal Revenue Code",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q4 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
... | [
42442,
51434,
60159,
53650,
42442,
51434,
53650,
60159,
42442,
51434,
60159,
53650
] | [
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null,
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the Presid... | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/6c87664b-6c58-48e8-ac74-f64fbcacfb2b/print/ | 6c87664b-6c58-48e8-ac74-f64fbcacfb2b | 6c87664b-6c58-48e8-ac74-f64fbcacfb2b_46038_153900 | astellas pharma us | 2018-01-12T18:28:49 |
YNCHF | 2018-01-19T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; S. 1519 and H.R. 2810, National Defense Authorization Act; Labor, HHS and Education FY18 Appropriations Bill"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q4 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/38ff5371-3304-4090-b20e-c1eafef01c6f/print/ | 38ff5371-3304-4090-b20e-c1eafef01c6f | 38ff5371-3304-4090-b20e-c1eafef01c6f_305054_181397 | astellas pharma us, inc. | 2018-01-19T19:13:35 |
YNCHF | 2018-01-22T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"- Issues related to Medicare Part B (HOPPS) and Part D \n- Provisions related to repeal of the Independent Payment Advisory Board (IPAB)",
"- Issues related to the Bayh-Dole Act (Pub. L. 96-517)\n- Issues related to drug pricing and value\n- Issues related to the importation of prescription medicines"
] | [
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q4 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY"
] | [
64580,
56477,
64580,
56477
] | [
null,
null,
null,
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/ff2095e0-04ca-468f-940e-7d0acc0841d3/print/ | ff2095e0-04ca-468f-940e-7d0acc0841d3 | ff2095e0-04ca-468f-940e-7d0acc0841d3_400762305_195037 | astellas pharma us, inc. | 2018-01-22T15:30:54 |
YNCHF | 2018-01-22T00:00:00 | astellas pharma us, inc. | Pharmacuetical company. | 60,000 | lobbying_income | service_provided | [
"issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. S.1519, the National Defense Authorization Act for 2018, Section 892, Rights in technical data related to medical research. HR 2819 - National Defense Authorization Act (FY18), Amendment 342, Rep. Doggett"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q4 | 2009-04-01 | null | DC | US | 1,005,002 | 0 | 0 | 2024-01-02T11:27:52.004862-05:00 | TIBER CREEK GROUP | 750 9th Street NW, Suite 501, Washington, DC, 20001, US | 20,744 | Government Relations. | GRACE BAUM | 31,587 | +1 202-381-6896 | [
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON"
] | [
47178,
26450,
6542
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/127151/ | https://lda.senate.gov/api/v1/registrants/20744/ | https://lda.senate.gov/filings/public/filing/1364bd26-6524-4372-804e-865690dd820e/print/ | 1364bd26-6524-4372-804e-865690dd820e | 1364bd26-6524-4372-804e-865690dd820e_20744_127151 | astellas pharma us, inc. | 2018-01-22T17:00:37 |
YNCHF | 2018-01-22T00:00:00 | astellas pharma us, inc. | null | 490,000 | a | service_provided | [
"Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment; comprehensive tax reform.",
"Issues related to oral chemotherapy in The Cancer Drug ... | [
"TAX - Taxation/Internal Revenue Code",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q4 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"SARAH CHRISTINE D'ORSIE",
"MARY LACEY REUTHER",
"SARAH CHRISTINE D'ORSIE",
"MARY LACEY REUTHER",
"SARAH CHRISTINE D'ORSIE"
] | [
54800,
64567,
54800,
64567,
54800,
64567
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/53058ccd-0182-4bce-a00b-ee44019503ef/print/ | 53058ccd-0182-4bce-a00b-ee44019503ef | 53058ccd-0182-4bce-a00b-ee44019503ef_40032268_188248 | astellas pharma us, inc. | 2018-01-22T20:45:03 |
YNCHF | 2018-04-06T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"National Defense Authorization Act for Fiscal Year 2019",
"Issues related to pharmaceutical pricing and NIH March In Rights",
"Issues related to pharmaceutical pricing"
] | [
"DEF - Defense",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q1 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
... | [
42442,
51434,
60159,
53650,
42442,
51434,
60159,
53650,
42442,
51434,
60159
] | [
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander;... | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/6ab31622-7c68-4a5b-9c6b-711c8ed7ff8d/print/ | 6ab31622-7c68-4a5b-9c6b-711c8ed7ff8d | 6ab31622-7c68-4a5b-9c6b-711c8ed7ff8d_46038_153900 | astellas pharma us | 2018-04-06T17:00:35 |
YNCHF | 2018-04-19T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 0 | lobbying_income | service_provided | [
"S. 2482; S.2039; H.R. 4170",
"Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing"
] | [
"GOV - Government Issues",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q1 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ",
"JEREMY RABINOVITZ"
] | [
61187,
61187
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/dfdfec80-12ee-4142-bb9a-174e3cf8c612/print/ | dfdfec80-12ee-4142-bb9a-174e3cf8c612 | dfdfec80-12ee-4142-bb9a-174e3cf8c612_305054_181397 | astellas pharma us, inc. | 2018-04-19T18:41:48 |
YNCHF | 2018-04-20T00:00:00 | astellas pharma us, inc. | Pharmacuetical company. | 60,000 | lobbying_income | service_provided | [
"issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. S.1519, the National Defense Authorization Act for 2018, Section 892, Rights in technical data related to medical research. HR 2819 - National Defense Authorization Act (FY18), Amendment 342, Rep. Doggett",
"S. 248... | [
"HCR - Health Issues",
"FOR - Foreign Relations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q1 | 2009-04-01 | null | DC | US | 1,005,002 | 0 | 0 | 2024-01-02T11:27:52.004862-05:00 | TIBER CREEK GROUP | 750 9th Street NW, Suite 501, Washington, DC, 20001, US | 20,744 | Government Relations. | GRACE BAUM | 31,587 | +1 202-381-6896 | [
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON",
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON"
] | [
47178,
26450,
6542,
47178,
26450,
6542
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/127151/ | https://lda.senate.gov/api/v1/registrants/20744/ | https://lda.senate.gov/filings/public/filing/19264120-31e4-4603-b1e4-79dd5180b210/print/ | 19264120-31e4-4603-b1e4-79dd5180b210 | 19264120-31e4-4603-b1e4-79dd5180b210_20744_127151 | astellas pharma us, inc. | 2018-04-20T16:22:22 |
YNCHF | 2018-04-20T00:00:00 | astellas pharma us, inc. | null | 780,000 | a | service_provided | [
"Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); Issues related to importation (no specific bills).",
"Issues related to Medicare Part D policy (no specific bills).",
"H.R. 4170 Disclosing Foreign Influence Act; S. 2482 Foreign Agents Registra... | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"LAW - Law Enforcement/Crime/Criminal Justice",
"TAX - Taxation/Internal Revenue Code"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q1 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"SARAH CHRISTINE D'ORSIE",
"VALARIE MOLAISON (Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH))",
"MARY LACEY REUTHER",
"SARAH CHRISTINE D'ORSIE",
"VALARIE MOLAISON (Congressional Science Fellow for Sen. Jon Tester (MT); ... | [
54800,
64567,
68274,
54800,
64567,
68274,
54800,
64567,
68274,
54800,
64567,
68274
] | [
null,
null,
"Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH)",
null,
null,
"Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH)",
null,
null,
"Congressional Science Fellow for ... | [
false,
false,
true,
false,
false,
true,
false,
false,
true,
false,
false,
true
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/453ae288-9660-402e-86d7-d7c5cd0cedb4/print/ | 453ae288-9660-402e-86d7-d7c5cd0cedb4 | 453ae288-9660-402e-86d7-d7c5cd0cedb4_40032268_188248 | astellas pharma us, inc. | 2018-04-20T20:09:40 |
YNCHF | 2018-04-20T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"- Issues related to the Bayh-Dole Act (Pub. L. 96-517)\n- Issues related to drug pricing and value, generally\n- Issues related to the importation of prescription medicines, generally",
"- Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Forei... | [
"HCR - Health Issues",
"FOR - Foreign Relations",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q1 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))",
"STEVEN E IRIZARRY",
... | [
64580,
56477,
66328,
56477,
64580,
66328,
64580,
56477,
66328
] | [
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)",
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floo... | [
false,
false,
true,
false,
false,
true,
false,
false,
true
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/cbd3aae6-7f91-4868-9cf5-9dd07882078b/print/ | cbd3aae6-7f91-4868-9cf5-9dd07882078b | cbd3aae6-7f91-4868-9cf5-9dd07882078b_400762305_195037 | astellas pharma us, inc. | 2018-04-20T20:12:25 |
YNCHF | 2018-05-03T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | modify_service | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing",
"S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Foreign Influence Act; H.R. 4170, Disclosing Foreign Influence Act."
] | [
"HCR - Health Issues",
"GOV - Government Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q1 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ",
"JEREMY RABINOVITZ"
] | [
61187,
61187
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/bca8a73e-3e64-4fc5-9cbe-39d5fdb83b75/print/ | bca8a73e-3e64-4fc5-9cbe-39d5fdb83b75 | bca8a73e-3e64-4fc5-9cbe-39d5fdb83b75_305054_181397 | astellas pharma us, inc. | 2018-05-03T19:13:37 |
YNCHF | 2018-05-17T00:00:00 | astellas pharma us, inc. | null | 574,908 | a | service_provided | [
"Tariff duty suspension",
"Issues related to the implementation of Section 501(c) of the 2005 Deficit Reduction Act; Issues related to hospital readmissions/bundling and home infusion therapy coverage (HR 574/S 254); The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565); I... | [
"TRD - Trade (domestic/foreign)",
"MMM - Medicare/Medicaid",
"TEC - Telecommunications",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2009-Q4 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MICHAEL RUGGIERO",
"SAMANTHA VENTIMIGLIA",
"MICHAEL RUGGIERO",
"SAMANTHA VENTIMIGLIA",
"MICHAEL RUGGIERO",
"SAMANTHA VENTIMIGLIA",
"MICHAEL RUGGIERO",
"SAMANTHA VENTIMIGLIA"
] | [
40398,
40403,
40398,
40403,
40398,
40403,
40398,
40403
] | [
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/bb14b071-79df-48d8-8248-87b0ed3d4c2b/print/ | bb14b071-79df-48d8-8248-87b0ed3d4c2b | bb14b071-79df-48d8-8248-87b0ed3d4c2b_40032268_188248 | astellas pharma us, inc. | null |
YNCHF | 2018-05-17T00:00:00 | astellas pharma us, inc. | null | 740,000 | a | service_provided | [
"Issues related to various patent reform bills (H.R.9, S.632, S.1137).",
"Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment.",
"Issues... | [
"CPT - Copyright/Patent/Trademark",
"TAX - Taxation/Internal Revenue Code",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2016-Q4 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"MELISSA WIER BANASHAK",
"SARAH CHRISTINE D'ORSIE (Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum)",
"MARY LACEY REUTHER",
"MELISSA WIER BANASHAK",
"SARAH CHRISTINE D'ORSIE",
"MARY LACEY REUTHER",
"MELISSA WIER BANASHAK",
"SARAH... | [
54800,
59772,
64567,
54800,
59772,
64567,
54800,
59772,
64567,
54800,
59772,
64567
] | [
null,
null,
"Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum",
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
true,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/482b9f27-ecb6-4314-a58e-266116a7677a/print/ | 482b9f27-ecb6-4314-a58e-266116a7677a | 482b9f27-ecb6-4314-a58e-266116a7677a_40032268_188248 | astellas pharma us, inc. | null |
YNCHF | 2018-07-09T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical pricing and NIH March In Rights",
"Issues related to pharmaceutical pricing",
"Disclosing Foreign Influence Act",
"National Defense Authorization Act for Fiscal Year 2019"
] | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"LAW - Law Enforcement/Crime/Criminal Justice",
"DEF - Defense"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q2 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
... | [
42442,
51434,
60159,
53650,
42442,
51434,
60159,
53650,
42442,
51434,
60159,
53650,
42442,
51434,
60159,
53650
] | [
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander;... | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/9bf4faa8-4e68-4e78-bd1a-79aef5d216c8/print/ | 9bf4faa8-4e68-4e78-bd1a-79aef5d216c8 | 9bf4faa8-4e68-4e78-bd1a-79aef5d216c8_46038_153900 | astellas pharma us | 2018-07-09T21:37:55 |
YNCHF | 2018-07-10T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | modify_service | [
"General health care issues, issues related to FDA, pharmaceuticals"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q1 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"KENNETH LEE HODGE"
] | [
42442,
51434,
60159,
139878
] | [
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/e2bee2a2-67b1-43eb-a3af-6b336aafdd89/print/ | e2bee2a2-67b1-43eb-a3af-6b336aafdd89 | e2bee2a2-67b1-43eb-a3af-6b336aafdd89_46038_153900 | astellas pharma us | 2018-07-10T15:03:11 |
YNCHF | 2018-07-19T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage.",
"S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Foreign Influence Act; H.R. 4170, Disclosing Foreign Influence Act."
] | [
"HCR - Health Issues",
"GOV - Government Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q2 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ",
"JEREMY RABINOVITZ"
] | [
61187,
61187
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/92aff7ad-48cc-46e9-872c-183c9b632538/print/ | 92aff7ad-48cc-46e9-872c-183c9b632538 | 92aff7ad-48cc-46e9-872c-183c9b632538_305054_181397 | astellas pharma us, inc. | 2018-07-19T20:17:38 |
YNCHF | 2018-07-20T00:00:00 | astellas pharma us, inc. | Pharmacuetical company. | 60,000 | lobbying_income | service_provided | [
"issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. S.1519, the National Defense Authorization Act for 2018, Section 892, Rights in technical data related to medical research. HR 2819 - National Defense Authorization Act (FY18), Amendment 342, Rep. Doggett",
"S. 248... | [
"HCR - Health Issues",
"FOR - Foreign Relations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q2 | 2009-04-01 | null | DC | US | 1,005,002 | 0 | 0 | 2024-01-02T11:27:52.004862-05:00 | TIBER CREEK GROUP | 750 9th Street NW, Suite 501, Washington, DC, 20001, US | 20,744 | Government Relations. | GRACE BAUM | 31,587 | +1 202-381-6896 | [
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON",
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON"
] | [
47178,
26450,
6542,
47178,
26450,
6542
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/127151/ | https://lda.senate.gov/api/v1/registrants/20744/ | https://lda.senate.gov/filings/public/filing/f7fc8ca2-fdb5-42e8-883e-a78886bda22e/print/ | f7fc8ca2-fdb5-42e8-883e-a78886bda22e | f7fc8ca2-fdb5-42e8-883e-a78886bda22e_20744_127151 | astellas pharma us, inc. | 2018-07-20T16:53:16 |
YNCHF | 2018-07-20T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"- Issues related to the Bayh-Dole Act (Pub. L. 96-517)\n- Issues related to drug pricing and value, generally\n- Issues related to the importation of prescription medicines, generally",
"- Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Forei... | [
"HCR - Health Issues",
"FOR - Foreign Relations",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q2 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))",
"STEVEN E IRIZARRY",
... | [
64580,
56477,
66328,
56477,
64580,
66328,
64580,
56477,
66328
] | [
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)",
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floo... | [
false,
false,
true,
false,
false,
true,
false,
false,
true
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/d9cb71e1-2819-4db4-ba5d-4516a0cb7305/print/ | d9cb71e1-2819-4db4-ba5d-4516a0cb7305 | d9cb71e1-2819-4db4-ba5d-4516a0cb7305_400762305_195037 | astellas pharma us, inc. | 2018-07-20T19:52:58 |
YNCHF | 2018-07-20T00:00:00 | astellas pharma us, inc. | null | 490,000 | a | service_provided | [
"House and Senate Appropriations for Fiscal Year ending Sept 30. 2018.",
"Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); PAHPA (S. 2852/H.R. 6378) Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; REVAMP (H.R. 6294) Re... | [
"BUD - Budget/Appropriations",
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"LAW - Law Enforcement/Crime/Criminal Justice"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q2 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY"
] | [
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
true,
false,
false,
true,
false,
false,
true,
false,
false,
true
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/6594c5fa-12c5-4c78-b38b-6ac23ab82ec1/print/ | 6594c5fa-12c5-4c78-b38b-6ac23ab82ec1 | 6594c5fa-12c5-4c78-b38b-6ac23ab82ec1_40032268_188248 | astellas pharma us, inc. | 2018-07-20T20:40:21 |
YNCHF | 2018-10-10T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical pricing and NIH March In Rights",
"Issues related to Medicare Part B and Medicare Part D"
] | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q3 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
... | [
42442,
51434,
60159,
53650,
42442,
51434,
60159,
53650
] | [
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander;... | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/9e88d2f6-88a3-4b01-afbf-acecee7e21b7/print/ | 9e88d2f6-88a3-4b01-afbf-acecee7e21b7 | 9e88d2f6-88a3-4b01-afbf-acecee7e21b7_46038_153900 | astellas pharma us | 2018-10-10T16:20:39 |
YNCHF | 2018-10-12T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage; HR 6505 Medicare Negotiation and Compulsory Act; HR 6294 REVAMP Act; Conference report to HR 6157.",
"S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Forei... | [
"HCR - Health Issues",
"GOV - Government Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q3 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ",
"JEREMY RABINOVITZ"
] | [
61187,
61187
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/85550049-8591-49b4-85e4-ad813ef5fd25/print/ | 85550049-8591-49b4-85e4-ad813ef5fd25 | 85550049-8591-49b4-85e4-ad813ef5fd25_305054_181397 | astellas pharma us, inc. | 2018-10-12T18:39:26 |
YNCHF | 2018-10-22T00:00:00 | astellas pharma us, inc. | null | 560,000 | a | service_provided | [
"House and Senate Appropriations for Fiscal Year ending Sept 30. 2018.",
"Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); PAHPA (S. 2852/H.R. 6378) Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; REVAMP (H.R. 6294) Re... | [
"BUD - Budget/Appropriations",
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"LAW - Law Enforcement/Crime/Criminal Justice"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q3 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY"
] | [
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/bd373f2f-d5ec-4906-b499-b367e6aaa532/print/ | bd373f2f-d5ec-4906-b499-b367e6aaa532 | bd373f2f-d5ec-4906-b499-b367e6aaa532_40032268_188248 | astellas pharma us, inc. | 2018-10-22T18:05:29 |
YNCHF | 2018-10-22T00:00:00 | astellas pharma us, inc. | Pharmacuetical company. | 60,000 | lobbying_income | service_provided | [
"S. 2482 - Foreign Agents Registration Amendment Act of 2018; S. 2039 - Disclosing Foreign Influence Act; HR 4170 - Disclosing Foreign Influence Act",
"Issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. Issues related to the Medicare Part D coverage gap"
] | [
"FOR - Foreign Relations",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q3 | 2009-04-01 | null | DC | US | 1,005,002 | 0 | 0 | 2024-01-02T11:27:52.004862-05:00 | TIBER CREEK GROUP | 750 9th Street NW, Suite 501, Washington, DC, 20001, US | 20,744 | Government Relations. | GRACE BAUM | 31,587 | +1 202-381-6896 | [
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON",
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON"
] | [
47178,
26450,
6542,
47178,
26450,
6542
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/127151/ | https://lda.senate.gov/api/v1/registrants/20744/ | https://lda.senate.gov/filings/public/filing/d0159c91-5999-4256-9031-aea95ba722e2/print/ | d0159c91-5999-4256-9031-aea95ba722e2 | d0159c91-5999-4256-9031-aea95ba722e2_20744_127151 | astellas pharma us, inc. | 2018-10-22T19:43:18 |
YNCHF | 2018-10-22T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"\"Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Foreign Agents Registration Amendments Act (S. 2482)\"",
"Issues related to Medicare Part D",
"HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. \nIssues related to the Bayh... | [
"LAW - Law Enforcement/Crime/Criminal Justice",
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q3 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"LYDIA STRUNK",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 ... | [
56477,
64580,
66328,
64580,
56477,
66328,
64580,
56477,
66328
] | [
null,
null,
null,
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)",
null,
null,
"Deputy Floor Director Speaker Rya... | [
false,
false,
false,
false,
false,
true,
false,
false,
true
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/20cc90e5-8bf0-462b-85af-59e5ecc36296/print/ | 20cc90e5-8bf0-462b-85af-59e5ecc36296 | 20cc90e5-8bf0-462b-85af-59e5ecc36296_400762305_195037 | astellas pharma us, inc. | 2018-10-22T20:57:00 |
YNCHF | 2019-01-09T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical pricing and NIH March In Rights",
"Issues related to Medicare Part B and Medicare Part D"
] | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q4 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
... | [
42442,
51434,
60159,
53650,
42442,
51434,
60159,
53650
] | [
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander;... | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/5f2a842a-4eab-490e-9388-5406a0ec1faa/print/ | 5f2a842a-4eab-490e-9388-5406a0ec1faa | 5f2a842a-4eab-490e-9388-5406a0ec1faa_46038_153900 | astellas pharma us | 2019-01-09T22:07:19 |
YNCHF | 2019-01-17T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage; HR 6505 Medicare Negotiation and Competitive Licensing Act",
"S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Foreign Influence Act; H.R. 4170, Disclosing ... | [
"HCR - Health Issues",
"GOV - Government Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"139 - Natl Institutes of Health (NIH)",
"1 - SENATE"
] | 2018-Q4 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ",
"JEREMY RABINOVITZ"
] | [
61187,
61187
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/23352e57-97ca-40b4-bb79-984cb8b4abdf/print/ | 23352e57-97ca-40b4-bb79-984cb8b4abdf | 23352e57-97ca-40b4-bb79-984cb8b4abdf_305054_181397 | astellas pharma us, inc. | 2019-01-17T18:14:01 |
YNCHF | 2019-01-18T00:00:00 | astellas pharma us, inc. | Pharmacuetical company. | 60,000 | lobbying_income | service_provided | [
"Issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. Issues related to the Medicare Part D coverage gap",
"S. 2482 - Foreign Agents Registration Amendment Act of 2018; S. 2039 - Disclosing Foreign Influence Act; HR 4170 - Disclosing Foreign Influence Act"
] | [
"HCR - Health Issues",
"FOR - Foreign Relations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q4 | 2009-04-01 | null | DC | US | 1,005,002 | 0 | 0 | 2024-01-02T11:27:52.004862-05:00 | TIBER CREEK GROUP | 750 9th Street NW, Suite 501, Washington, DC, 20001, US | 20,744 | Government Relations. | GRACE BAUM | 31,587 | +1 202-381-6896 | [
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON",
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON"
] | [
47178,
26450,
6542,
47178,
26450,
6542
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/127151/ | https://lda.senate.gov/api/v1/registrants/20744/ | https://lda.senate.gov/filings/public/filing/e36ab401-47c7-4539-9879-ef04f90431dd/print/ | e36ab401-47c7-4539-9879-ef04f90431dd | e36ab401-47c7-4539-9879-ef04f90431dd_20744_127151 | astellas pharma us, inc. | 2019-01-18T19:47:09 |
YNCHF | 2019-01-21T00:00:00 | astellas pharma us, inc. | null | 460,000 | a | service_provided | [
"Issues related to Medicare Part D policy (no specific bills).",
"Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); PAHPA (S. 2852/H.R. 6378) Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; REVAMP (H.R. 6294) Re-Valuing... | [
"MMM - Medicare/Medicaid",
"HCR - Health Issues",
"BUD - Budget/Appropriations",
"LAW - Law Enforcement/Crime/Criminal Justice"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q4 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY"
] | [
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/0a9d5ab3-b43b-4e6b-9039-f063d656eb86/print/ | 0a9d5ab3-b43b-4e6b-9039-f063d656eb86 | 0a9d5ab3-b43b-4e6b-9039-f063d656eb86_40032268_188248 | astellas pharma us, inc. | 2019-01-21T20:04:18 |
YNCHF | 2019-01-22T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. \nIssues related to the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally\nPandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) (S. 2852/H.R. 6378) \nIssues related to the importation of presc... | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"LAW - Law Enforcement/Crime/Criminal Justice"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q4 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))",
"VINCENT A. ROBERTI, SR... | [
64580,
56477,
66328,
64580,
56477,
66328,
56477,
64580,
66328
] | [
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)",
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floo... | [
false,
false,
true,
false,
false,
true,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/3c703155-5941-4043-b969-1598781b7589/print/ | 3c703155-5941-4043-b969-1598781b7589 | 3c703155-5941-4043-b969-1598781b7589_400762305_195037 | astellas pharma us, inc. | 2019-01-22T20:52:43 |
YNCHF | 2019-02-12T00:00:00 | astellas pharma us, inc. | Client is a pharmaceutical company. | 7,500 | lobbying_income | modify_service | [
"Development of policies to advance the antimicrobial research and development environment"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2013-Q4 | 2013-09-16 | null | IL | US | 393 | 0 | 0 | 2024-01-31T11:02:48.049026-05:00 | THE MCMANUS GROUP | 610 10th St. NW, Suite 300, Washington, DC, 20001, US | 286,096 | Consulting | NATE GASPAR | 36,969 | +1 434-989-7548 | [
"BARRETT THORNHILL",
"JOHN MCMANUS"
] | [
59333,
9573
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/176451/ | https://lda.senate.gov/api/v1/registrants/286096/ | https://lda.senate.gov/filings/public/filing/9d700112-c269-47fa-9d5d-f4cb4c734a82/print/ | 9d700112-c269-47fa-9d5d-f4cb4c734a82 | 9d700112-c269-47fa-9d5d-f4cb4c734a82_286096_176451 | astellas pharma us, inc. | 2019-02-12T17:08:10 |
YNCHF | 2019-04-04T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical pricing and NIH March In Rights"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q1 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)"
] | [
42442,
51434,
60159,
53650
] | [
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President"
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/1d951110-e389-4c96-b5be-b5ff6029d37d/print/ | 1d951110-e389-4c96-b5be-b5ff6029d37d | 1d951110-e389-4c96-b5be-b5ff6029d37d_46038_153900 | astellas pharma us | 2019-04-04T19:10:20 |
YNCHF | 2019-04-18T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"H.R. 1, For the People Act of 2019, provisions and amendments related to FARA registration and PACS for foreign-owned subsidiaries of US companies",
"Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage; H.R. 1046, Medicare Negotiation and C... | [
"GOV - Government Issues",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q1 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ",
"JEREMY RABINOVITZ"
] | [
61187,
61187
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/d4d6b792-bd2c-44d4-9aa6-471e42829b6d/print/ | d4d6b792-bd2c-44d4-9aa6-471e42829b6d | d4d6b792-bd2c-44d4-9aa6-471e42829b6d_305054_181397 | astellas pharma us, inc. | 2019-04-18T17:54:00 |
YNCHF | 2019-04-22T00:00:00 | astellas pharma us, inc. | null | 540,000 | a | service_provided | [
"Biopharmaceutical innovation and patent policy issues.",
"H.R. 1 - For the People Act of 2019",
"Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); PAHPA (S. 2852/H.R. 6378).",
"Issues related to Medicare Part D policies, including non-interfe... | [
"CPT - Copyright/Patent/Trademark",
"LAW - Law Enforcement/Crime/Criminal Justice",
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q1 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEP... | [
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/cfde7334-b08c-43f7-a909-1b556f2d0b52/print/ | cfde7334-b08c-43f7-a909-1b556f2d0b52 | cfde7334-b08c-43f7-a909-1b556f2d0b52_40032268_188248 | astellas pharma us, inc. | 2019-04-22T17:59:08 |
YNCHF | 2019-04-22T00:00:00 | astellas pharma us, inc. | Pharmacuetical company. | 60,000 | lobbying_income | terminate | [
"HR 1 - Title IV - Campaign Finance Transparency",
"Issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517, and transparency. Issues related to the Medicare Part D pricing reform."
] | [
"FOR - Foreign Relations",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q1 | 2009-04-01 | 2019-03-31 | DC | US | 1,005,002 | 0 | 0 | 2024-01-02T11:27:52.004862-05:00 | TIBER CREEK GROUP | 750 9th Street NW, Suite 501, Washington, DC, 20001, US | 20,744 | Government Relations. | GRACE BAUM | 31,587 | +1 202-381-6896 | [
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON",
"JOHN MICHAEL GONZALEZ",
"JONATHON JONES",
"SEAN RICHARDSON"
] | [
47178,
26450,
6542,
47178,
26450,
6542
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/127151/ | https://lda.senate.gov/api/v1/registrants/20744/ | https://lda.senate.gov/filings/public/filing/bc213f95-4158-45bb-874c-9a3063096611/print/ | bc213f95-4158-45bb-874c-9a3063096611 | bc213f95-4158-45bb-874c-9a3063096611_20744_127151 | astellas pharma us, inc. | 2019-04-22T20:02:32 |
YNCHF | 2019-04-22T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally\nPandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA)\nIssues related to the importation of prescr... | [
"HCR - Health Issues",
"LAW - Law Enforcement/Crime/Criminal Justice",
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q1 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))",
"STEVEN E IRIZARRY",
... | [
64580,
56477,
66328,
56477,
64580,
66328,
64580,
56477,
66328,
56477,
64580,
66328
] | [
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)",
null,
null,
null,
null,
null,
"Deputy Floor Director Speaker Rya... | [
false,
false,
true,
false,
false,
false,
false,
false,
true,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/056f5c8d-53e7-4cba-85ff-7f2ea26bc2f4/print/ | 056f5c8d-53e7-4cba-85ff-7f2ea26bc2f4 | 056f5c8d-53e7-4cba-85ff-7f2ea26bc2f4_400762305_195037 | astellas pharma us, inc. | 2019-04-23T02:01:19 |
YNCHF | 2019-05-22T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 5,000 | lobbying_income | retainer | [] | null | null | 2019-Q1 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | null | null | null | null | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/30c8e70b-1f4e-4e0a-8375-4e74ada4379a/print/ | 30c8e70b-1f4e-4e0a-8375-4e74ada4379a | 30c8e70b-1f4e-4e0a-8375-4e74ada4379a_76833_169120 | astellas pharma us, inc. | 2019-05-22T19:34:01 |
YNCHF | 2019-07-12T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical pricing and NIH March In Rights"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q2 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"KENNETH LEE HODGE"
] | [
42442,
51434,
53650,
139878
] | [
null,
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/68e55d5a-918d-47cb-9c0a-ca553f3b4edf/print/ | 68e55d5a-918d-47cb-9c0a-ca553f3b4edf | 68e55d5a-918d-47cb-9c0a-ca553f3b4edf_46038_153900 | astellas pharma us | 2019-07-12T17:01:19 |
YNCHF | 2019-07-22T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"General issues related to FARA registration for foreign-owned subsidiaries of US companies",
"Issues related to P.L. 96-517, the Bayh-Dole Act; S.1416, the Affordable Prescriptions for Patients Act; issues related to drug pricing; issues related to Medicare Part D coverage; H.R. 1046, Medicare Negotiation and Co... | [
"GOV - Government Issues",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q2 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ",
"JEREMY RABINOVITZ"
] | [
61187,
61187
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/fda29f0a-5b9d-4da0-b9f8-8d0202ced030/print/ | fda29f0a-5b9d-4da0-b9f8-8d0202ced030 | fda29f0a-5b9d-4da0-b9f8-8d0202ced030_305054_181397 | astellas pharma us, inc. | 2019-07-22T15:31:14 |
YNCHF | 2019-07-22T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 60,000 | lobbying_income | service_provided | [
"Intellectual property, data exclusivity and patent eligibility, generally; \nCREATES Act of 2019 (S.340)/(H.R.965);\nPreserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); \nStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); \nPres... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q2 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"ANDREA LARUE",
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW",
"ANDREA LARUE"
] | [
20565,
38865,
35167,
69878,
20565
] | [
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/f7da1b64-6372-4317-870c-e5bfe3f9794d/print/ | f7da1b64-6372-4317-870c-e5bfe3f9794d | f7da1b64-6372-4317-870c-e5bfe3f9794d_76833_169120 | astellas pharma us, inc. | 2019-07-22T16:37:35 |
YNCHF | 2019-07-22T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally",
"Issues related to Medicare Part D, including non-interference, rebate policy issues\nIssues related to drug pricing... | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations",
"LAW - Law Enforcement/Crime/Criminal Justice"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q2 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))",
"VINCENT A. ROBERTI, SR... | [
64580,
56477,
66328,
64580,
56477,
66328,
56477,
64580,
66328,
56477,
64580,
66328
] | [
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)",
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floo... | [
false,
false,
true,
false,
false,
true,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/6fcea9ab-b611-4483-aad2-ec481d326a54/print/ | 6fcea9ab-b611-4483-aad2-ec481d326a54 | 6fcea9ab-b611-4483-aad2-ec481d326a54_400762305_195037 | astellas pharma us, inc. | 2019-07-22T18:02:34 |
YNCHF | 2019-07-22T00:00:00 | astellas pharma us, inc. | null | 340,000 | a | service_provided | [
"Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).",
"Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).",
"Issues related to Medicare Part D policies, including non-interference an... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q2 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY"
] | [
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/3301a4de-a644-46af-bcbd-2eb12679f1bb/print/ | 3301a4de-a644-46af-bcbd-2eb12679f1bb | 3301a4de-a644-46af-bcbd-2eb12679f1bb_40032268_188248 | astellas pharma us, inc. | 2019-07-22T18:19:17 |
YNCHF | 2019-10-18T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical drugs"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q3 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"KENNETH LEE HODGE"
] | [
42442,
51434,
53650,
139878
] | [
null,
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/592d4a72-154e-4772-ab0e-6cf630ac87cb/print/ | 592d4a72-154e-4772-ab0e-6cf630ac87cb | 592d4a72-154e-4772-ab0e-6cf630ac87cb_46038_153900 | astellas pharma us | 2019-10-18T18:49:26 |
YNCHF | 2019-10-21T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; H.R. 1046, Medicare Negotiation and Competitive Licensing Act; S. 2387, PAID Act; H.R. 3877, Bipartisan Budget Act of 2019; H.R. 3, Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q3 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/2ff2d1ba-1e73-4e78-aa6f-5472fa4e6cfc/print/ | 2ff2d1ba-1e73-4e78-aa6f-5472fa4e6cfc | 2ff2d1ba-1e73-4e78-aa6f-5472fa4e6cfc_305054_181397 | astellas pharma us, inc. | 2019-10-21T18:40:01 |
YNCHF | 2019-10-21T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 60,000 | lobbying_income | service_provided | [
"Intellectual property, data exclusivity and patent eligibility, generally; \nCREATES Act of 2019 (S.340)/(H.R.965);\nPreserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); \nStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); \nAffo... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q3 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"ANDREA LARUE",
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW",
"ANDREA LARUE"
] | [
20565,
38865,
35167,
69878,
20565
] | [
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/290005fd-be40-456e-8a46-8b62d249804e/print/ | 290005fd-be40-456e-8a46-8b62d249804e | 290005fd-be40-456e-8a46-8b62d249804e_76833_169120 | astellas pharma us, inc. | 2019-10-21T21:40:06 |
YNCHF | 2019-10-21T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally",
"Issues related to Medicare Part D, including non-interference, rebate policy issues\nIssues related to drug pricing... | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"LAW - Law Enforcement/Crime/Criminal Justice",
"BUD - Budget/Appropriations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q3 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))",
"VINCENT A. ROBERTI, SR... | [
64580,
56477,
66328,
64580,
56477,
66328,
56477,
64580,
66328,
56477,
64580,
66328
] | [
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)",
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floo... | [
false,
false,
true,
false,
false,
true,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/e8d42e44-80ac-4f2c-a5b8-edb2f5973b7c/print/ | e8d42e44-80ac-4f2c-a5b8-edb2f5973b7c | e8d42e44-80ac-4f2c-a5b8-edb2f5973b7c_400762305_195037 | astellas pharma us, inc. | 2019-10-21T21:44:39 |
YNCHF | 2019-10-21T00:00:00 | astellas pharma us, inc. | null | 410,000 | a | service_provided | [
"House and Senate Appropriations for Fiscal Year ending Sept 30, 2019.",
"Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).",
"Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).",
... | [
"BUD - Budget/Appropriations",
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q3 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY"
] | [
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/ea2b68c6-560a-41bd-9a28-bf27ed0313f9/print/ | ea2b68c6-560a-41bd-9a28-bf27ed0313f9 | ea2b68c6-560a-41bd-9a28-bf27ed0313f9_40032268_188248 | astellas pharma us, inc. | 2019-10-21T21:59:57 |
YNCHF | 2019-10-24T00:00:00 | astellas pharma us, inc. | Pharmaceutical manufacturer. | 60,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D and prescription drug pricing.",
"Issues related to Medicare Part D and prescription drug pricing."
] | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q3 | 2019-07-01 | null | IL | US | 1,007,033 | 0 | null | 2024-01-30T13:15:28.215474-05:00 | CAPITOL COUNSEL LLC | 700 13th Street NW, 2nd Floor, Washington, DC, 20005, US | 313,715 | Government affairs. | TRACEY A. GRAY | 39,384 | +1 202-861-3200 | [
"SHANNON FINLEY",
"ANN JABLON",
"SHANNON FINLEY",
"ANN JABLON"
] | [
45351,
65069,
45351,
65069
] | [
null,
null,
null,
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/184651/ | https://lda.senate.gov/api/v1/registrants/313715/ | https://lda.senate.gov/filings/public/filing/ff3f5809-b8ec-410e-9a49-5ae15e780f92/print/ | ff3f5809-b8ec-410e-9a49-5ae15e780f92 | ff3f5809-b8ec-410e-9a49-5ae15e780f92_313715_184651 | astellas pharma us, inc. | 2019-10-24T14:07:50 |
YNCHF | 2020-01-10T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 60,000 | lobbying_income | service_provided | [
"Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895.",
"Intellectual property, data exclusivity and patent eligibility, generally; \n... | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q4 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW",
"ANDREA LARUE",
"ANDREA LARUE"
] | [
38865,
35167,
69878,
20565,
20565
] | [
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/4278067f-7135-4404-b9e3-0366b3d9a2fa/print/ | 4278067f-7135-4404-b9e3-0366b3d9a2fa | 4278067f-7135-4404-b9e3-0366b3d9a2fa_76833_169120 | astellas pharma us, inc. | 2020-01-10T20:10:27 |
YNCHF | 2020-01-13T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; H.R. 1046, Medicare Negotiation and Competitive Licensing Act; H.R. 3, Lower Drug Costs Now Act."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q4 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/3942a761-290d-4896-b469-27446451c230/print/ | 3942a761-290d-4896-b469-27446451c230 | 3942a761-290d-4896-b469-27446451c230_305054_181397 | astellas pharma us, inc. | 2020-01-13T19:52:55 |
YNCHF | 2020-01-19T00:00:00 | astellas pharma us, inc. | Pharmaceutical manufacturer. | 60,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D and prescription drug pricing.",
"Issues related to Medicare Part D and prescription drug pricing."
] | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q4 | 2019-07-01 | null | IL | US | 1,007,033 | 0 | null | 2024-01-30T13:15:28.215474-05:00 | CAPITOL COUNSEL LLC | 700 13th Street NW, 2nd Floor, Washington, DC, 20005, US | 313,715 | Government affairs. | TRACEY A. GRAY | 39,384 | +1 202-861-3200 | [
"SHANNON FINLEY",
"ANN JABLON",
"SHANNON FINLEY",
"ANN JABLON"
] | [
45351,
65069,
45351,
65069
] | [
null,
null,
null,
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/184651/ | https://lda.senate.gov/api/v1/registrants/313715/ | https://lda.senate.gov/filings/public/filing/c1965475-a0e3-4563-a7fe-a0e6432c5218/print/ | c1965475-a0e3-4563-a7fe-a0e6432c5218 | c1965475-a0e3-4563-a7fe-a0e6432c5218_313715_184651 | astellas pharma us, inc. | 2020-01-19T22:00:49 |
YNCHF | 2020-01-21T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 0 | lobbying_income | service_provided | [
"Issues related to lobbying disclosure for US affiliates",
"HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally",
"Issues related to Medicare Part D, including non-inter... | [
"LAW - Law Enforcement/Crime/Criminal Justice",
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q4 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"LYDIA STRUNK",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 ... | [
56477,
64580,
66328,
64580,
56477,
66328,
64580,
56477,
66328,
56477,
64580,
66328
] | [
null,
null,
null,
null,
null,
"Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)",
null,
null,
"Deputy Floor Director Speaker Rya... | [
false,
false,
false,
false,
false,
true,
false,
false,
true,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/ef7e0b2c-14ba-4e96-b11b-a79d26542c1b/print/ | ef7e0b2c-14ba-4e96-b11b-a79d26542c1b | ef7e0b2c-14ba-4e96-b11b-a79d26542c1b_400762305_195037 | astellas pharma us, inc. | 2020-01-21T16:00:56 |
YNCHF | 2020-01-21T00:00:00 | astellas pharma us, inc. | null | 670,000 | a | service_provided | [
"Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).",
"Value of Prescription Drugs, Senate & House; Issues related to Bayh-Dole Act (Pub. L. 96-517).",
"Issues related to Medicare Part D policies, including non-interference and rebate policy issues... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q4 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY"
] | [
54800,
68274,
68416,
68416,
54800,
68274,
54800,
68274,
68416,
54800,
68274,
68416
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/420dbb8b-4942-486e-9f26-62a59b9010ec/print/ | 420dbb8b-4942-486e-9f26-62a59b9010ec | 420dbb8b-4942-486e-9f26-62a59b9010ec_40032268_188248 | astellas pharma us, inc. | 2020-01-21T22:26:18 |
YNCHF | 2020-01-22T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical drugs"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q4 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"KENNETH LEE HODGE"
] | [
42442,
51434,
53650,
139878
] | [
null,
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/fa176192-68c1-4f79-9ea0-d5752c61792e/print/ | fa176192-68c1-4f79-9ea0-d5752c61792e | fa176192-68c1-4f79-9ea0-d5752c61792e_46038_153900 | astellas pharma us | 2020-01-22T03:47:44 |
YNCHF | 2020-01-22T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | modify_service | [
"House and Senate Appropriations for FY ending Sept. 30, 2019",
"HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally",
"Issues related to lobbying disclosure for US affi... | [
"BUD - Budget/Appropriations",
"HCR - Health Issues",
"LAW - Law Enforcement/Crime/Criminal Justice",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q4 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY"
] | [
56477,
64580,
64580,
56477,
56477,
64580,
64580,
56477
] | [
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/47cb4cc6-4a4a-44f2-a8f3-295b3d544fed/print/ | 47cb4cc6-4a4a-44f2-a8f3-295b3d544fed | 47cb4cc6-4a4a-44f2-a8f3-295b3d544fed_400762305_195037 | astellas pharma us, inc. | 2020-01-22T18:37:33 |
YNCHF | 2020-04-16T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; general issues pertaining to the cost of prescription drugs."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q1 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/592021a2-7818-49fa-be8f-ef492196e3ea/print/ | 592021a2-7818-49fa-be8f-ef492196e3ea | 592021a2-7818-49fa-be8f-ef492196e3ea_305054_181397 | astellas pharma us, inc. | 2020-04-16T14:15:48 |
YNCHF | 2020-04-17T00:00:00 | astellas pharma us, inc. | Pharmaceutical manufacturer. | 60,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid... | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q1 | 2019-07-01 | null | IL | US | 1,007,033 | 0 | null | 2024-01-30T13:15:28.215474-05:00 | CAPITOL COUNSEL LLC | 700 13th Street NW, 2nd Floor, Washington, DC, 20005, US | 313,715 | Government affairs. | TRACEY A. GRAY | 39,384 | +1 202-861-3200 | [
"SHANNON FINLEY",
"ANN JABLON"
] | [
45351,
65069
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/184651/ | https://lda.senate.gov/api/v1/registrants/313715/ | https://lda.senate.gov/filings/public/filing/8e5b18e3-df7b-4f4b-b3cf-dacfd497a141/print/ | 8e5b18e3-df7b-4f4b-b3cf-dacfd497a141 | 8e5b18e3-df7b-4f4b-b3cf-dacfd497a141_313715_184651 | astellas pharma us, inc. | 2020-04-17T21:50:02 |
YNCHF | 2020-04-20T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical drugs"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q1 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN R RAY (Legislative Assistant, Rep. M... | [
42442,
51434,
53650,
60159,
67296,
68519,
139878
] | [
null,
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
"Legislative Director, Rep. Marsha Blackburn",
"Legislative Assistant, Rep. Mike Kelly",
null,
null
] | [
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/79f27f41-42c2-4a95-91ae-0d11f7780d33/print/ | 79f27f41-42c2-4a95-91ae-0d11f7780d33 | 79f27f41-42c2-4a95-91ae-0d11f7780d33_46038_153900 | astellas pharma us | 2020-04-20T22:34:42 |
YNCHF | 2020-04-20T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"Issues related to lobbying disclosure for US affiliates",
"Issues related to Medicare Part D, including non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally",
"HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rig... | [
"LAW - Law Enforcement/Crime/Criminal Justice",
"MMM - Medicare/Medicaid",
"HCR - Health Issues",
"BUD - Budget/Appropriations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q1 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR."
] | [
56477,
64580,
64580,
56477,
64580,
56477,
56477,
64580
] | [
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/f1d0b8c2-2992-4c1a-ba74-d00231018f5c/print/ | f1d0b8c2-2992-4c1a-ba74-d00231018f5c | f1d0b8c2-2992-4c1a-ba74-d00231018f5c_400762305_195037 | astellas pharma us, inc. | 2020-04-20T16:49:34 |
YNCHF | 2020-04-20T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 60,000 | lobbying_income | service_provided | [
"Intellectual property, data exclusivity and patent eligibility, generally; \nCREATES Act of 2019 (S.340)/(H.R.965);\nPreserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); \nStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); \nAffo... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q1 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"ANDREA LARUE",
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW"
] | [
20565,
38865,
35167,
69878
] | [
null,
null,
null,
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/e8dac362-954f-49d1-917f-180c817eb9a7/print/ | e8dac362-954f-49d1-917f-180c817eb9a7 | e8dac362-954f-49d1-917f-180c817eb9a7_76833_169120 | astellas pharma us, inc. | 2020-04-20T20:17:09 |
YNCHF | 2020-04-20T00:00:00 | astellas pharma us, inc. | null | 270,000 | a | service_provided | [
"Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).",
"Value of Prescription Drugs, Senate & House; Issues related to Bayh-Dole Act (Pub. L. 96-517).",
"Issues related to Medicare Part D policies, including non-interference and rebate policy issues... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q1 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY"
] | [
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/8588e876-621e-4dc7-a6b6-1d8bcb4390f5/print/ | 8588e876-621e-4dc7-a6b6-1d8bcb4390f5 | 8588e876-621e-4dc7-a6b6-1d8bcb4390f5_40032268_188248 | astellas pharma us, inc. | 2020-04-20T21:56:22 |
YNCHF | 2020-07-17T00:00:00 | astellas pharma us, inc. | null | 510,000 | a | service_provided | [
"Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).",
"Value of Prescription Drugs, Senate & House; Issues related to Bayh-Dole Act (Pub. L. 96-517). Issues related to pharmaceutical supply chain, COVID-19 response and health appropriations (no speci... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q2 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"MARY LACEY REUTHER",
"VALARIE MOLAISON",
"JOSEPH DEVANEY"
] | [
54800,
68274,
68416,
54800,
68274,
68416,
54800,
68274,
68416
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/43964215-024c-4996-8d5b-dd892c32911f/print/ | 43964215-024c-4996-8d5b-dd892c32911f | 43964215-024c-4996-8d5b-dd892c32911f_40032268_188248 | astellas pharma us, inc. | 2020-07-17T20:01:42 |
YNCHF | 2020-07-17T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; general issues pertaining to the cost of prescription drugs; general issues related to the pharmaceutical supply chain; general issues related to drug innovation; H.R. 1425, Patient Protection and Affordable Care Enhancement Act."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q2 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/efa660cf-1617-4b2e-ab00-5361083bfa96/print/ | efa660cf-1617-4b2e-ab00-5361083bfa96 | efa660cf-1617-4b2e-ab00-5361083bfa96_305054_181397 | astellas pharma us, inc. | 2020-07-17T20:13:08 |
YNCHF | 2020-07-20T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical drugs"
] | [
"HCR - Health Issues"
] | [
"11 - Executive Office of the President (EOP)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q2 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN R RAY (Legislative Assistant, Rep. M... | [
42442,
51434,
53650,
60159,
67296,
68519,
139878
] | [
null,
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
"Legislative Director, Rep. Marsha Blackburn",
"Legislative Assistant, Rep. Mike Kelly",
null,
null
] | [
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/49c94325-5617-4967-b023-268a7e15b9bd/print/ | 49c94325-5617-4967-b023-268a7e15b9bd | 49c94325-5617-4967-b023-268a7e15b9bd_46038_153900 | astellas pharma us | 2020-07-20T22:33:26 |
YNCHF | 2020-07-20T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 60,000 | lobbying_income | service_provided | [
"Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895.",
"H.R. 6395 - National Defense Authorization Act for Fiscal Year 2021.",
"Int... | [
"HCR - Health Issues",
"DEF - Defense",
"CPT - Copyright/Patent/Trademark"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q2 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW",
"IRENE BUENO",
"LISA GERMAN FOSTER",
"ANDREA LARUE"
] | [
38865,
35167,
69878,
35167,
38865,
20565
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/a3a1001b-c9d3-4c30-a4be-c549242e2547/print/ | a3a1001b-c9d3-4c30-a4be-c549242e2547 | a3a1001b-c9d3-4c30-a4be-c549242e2547_76833_169120 | astellas pharma us, inc. | 2020-07-20T19:42:57 |
YNCHF | 2020-07-20T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D, including reforms, non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally",
"House and Senate Appropriations for FY 2021",
"Issues related to lobbying disclosure for US affiliates",
"HHS Blueprint to Lower Drug Prices and ... | [
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations",
"LAW - Law Enforcement/Crime/Criminal Justice",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q2 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY"
] | [
64580,
56477,
56477,
64580,
56477,
64580,
64580,
56477
] | [
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/cb34dccb-8aff-4aec-9973-6031b6765d5a/print/ | cb34dccb-8aff-4aec-9973-6031b6765d5a | cb34dccb-8aff-4aec-9973-6031b6765d5a_400762305_195037 | astellas pharma us, inc. | 2020-07-20T21:56:46 |
YNCHF | 2020-07-20T00:00:00 | astellas pharma us, inc. | Pharmaceutical manufacturer. | 50,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid... | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q2 | 2019-07-01 | null | IL | US | 1,007,033 | 0 | null | 2024-01-30T13:15:28.215474-05:00 | CAPITOL COUNSEL LLC | 700 13th Street NW, 2nd Floor, Washington, DC, 20005, US | 313,715 | Government affairs. | TRACEY A. GRAY | 39,384 | +1 202-861-3200 | [
"SHANNON FINLEY",
"ANN JABLON"
] | [
45351,
65069
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/184651/ | https://lda.senate.gov/api/v1/registrants/313715/ | https://lda.senate.gov/filings/public/filing/5e35eaf4-ebb2-4869-89d4-5f4d9da949a3/print/ | 5e35eaf4-ebb2-4869-89d4-5f4d9da949a3 | 5e35eaf4-ebb2-4869-89d4-5f4d9da949a3_313715_184651 | astellas pharma us, inc. | 2020-07-21T00:27:18 |
YNCHF | 2020-10-15T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to P.L. 96-517, the Bayh-Dole Act; general issues pertaining to the cost of prescription drugs; general issues related to the pharmaceutical supply chain; general issues related to drug innovation."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q3 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/c4896666-17e9-4f61-9524-2d80a037f1b9/print/ | c4896666-17e9-4f61-9524-2d80a037f1b9 | c4896666-17e9-4f61-9524-2d80a037f1b9_305054_181397 | astellas pharma us, inc. | 2020-10-15T14:04:22 |
YNCHF | 2020-10-15T00:00:00 | astellas pharma us, inc. | Pharmaceutical manufacturer. | 50,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid... | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q3 | 2019-07-01 | null | IL | US | 1,007,033 | 0 | null | 2024-01-30T13:15:28.215474-05:00 | CAPITOL COUNSEL LLC | 700 13th Street NW, 2nd Floor, Washington, DC, 20005, US | 313,715 | Government affairs. | TRACEY A. GRAY | 39,384 | +1 202-861-3200 | [
"SHANNON FINLEY",
"ANN JABLON"
] | [
45351,
65069
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/184651/ | https://lda.senate.gov/api/v1/registrants/313715/ | https://lda.senate.gov/filings/public/filing/04c835bf-c458-4c3c-9a79-630dfe3177c9/print/ | 04c835bf-c458-4c3c-9a79-630dfe3177c9 | 04c835bf-c458-4c3c-9a79-630dfe3177c9_313715_184651 | astellas pharma us, inc. | 2020-10-16T01:34:33 |
YNCHF | 2020-10-19T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | service_provided | [
"HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally",
"House and Senate Appropriations for FY 2021",
"Issues related to Medicare Part D, including reforms, non-interfer... | [
"HCR - Health Issues",
"BUD - Budget/Appropriations",
"MMM - Medicare/Medicaid",
"LAW - Law Enforcement/Crime/Criminal Justice"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q3 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR."
] | [
64580,
56477,
56477,
64580,
64580,
56477,
56477,
64580
] | [
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/a7ce17ae-c7b9-4ac0-8e1a-27ae6aae11bb/print/ | a7ce17ae-c7b9-4ac0-8e1a-27ae6aae11bb | a7ce17ae-c7b9-4ac0-8e1a-27ae6aae11bb_400762305_195037 | astellas pharma us, inc. | 2020-10-19T17:14:53 |
YNCHF | 2020-10-19T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 60,000 | lobbying_income | service_provided | [
"Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895.",
"H.R. 6395/S. 4049 - National Defense Authorization Act for Fiscal Year 2021."... | [
"HCR - Health Issues",
"DEF - Defense"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q3 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW",
"IRENE BUENO",
"LISA GERMAN FOSTER"
] | [
38865,
35167,
69878,
35167,
38865
] | [
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/36269aa5-4506-42fa-9193-97ea19acfb21/print/ | 36269aa5-4506-42fa-9193-97ea19acfb21 | 36269aa5-4506-42fa-9193-97ea19acfb21_76833_169120 | astellas pharma us, inc. | 2020-10-19T20:15:58 |
YNCHF | 2020-10-20T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical drugs"
] | [
"HCR - Health Issues"
] | [
"11 - Executive Office of the President (EOP)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q3 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN R RAY (Legislative Assistant, Rep. M... | [
42442,
51434,
53650,
60159,
67296,
68519,
139878
] | [
null,
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
"Legislative Director, Rep. Marsha Blackburn",
"Legislative Assistant, Rep. Mike Kelly",
null,
null
] | [
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/2df41571-4f1f-48b3-9074-9d35ce02a24b/print/ | 2df41571-4f1f-48b3-9074-9d35ce02a24b | 2df41571-4f1f-48b3-9074-9d35ce02a24b_46038_153900 | astellas pharma us | 2020-10-21T00:26:15 |
YNCHF | 2020-10-20T00:00:00 | astellas pharma us, inc. | null | 550,000 | a | service_provided | [
"Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).",
"Value of Prescription Drugs, Senate & House. Issues related to Bayh-Dole Act (Pub. L. 96-517). Issues related to pharmaceutical supply chain management, S.3537 Protecting Our Pharmaceutical Suppl... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q3 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"VALARIE MOLAISON",
"JOSEPH DEVANEY",
"VALARIE MOLAISON",
"JOSEPH DEVANEY"
] | [
68274,
68416,
68274,
68416,
68274,
68416
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/df954b7e-c346-45bc-a725-090336ff5bba/print/ | df954b7e-c346-45bc-a725-090336ff5bba | df954b7e-c346-45bc-a725-090336ff5bba_40032268_188248 | astellas pharma us, inc. | 2020-10-20T15:00:11 |
YNCHF | 2021-01-19T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"General issues pertaining to the cost of prescription drugs; general issues related to drug research and innovation; Consolidated Appropriations Act of 2021, provision concerning Medicare Part B sequestration reimbursements."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/e8110879-d602-454f-99ad-982adcadc973/print/ | e8110879-d602-454f-99ad-982adcadc973 | e8110879-d602-454f-99ad-982adcadc973_305054_181397 | astellas pharma us, inc. | 2021-01-19T22:09:54 |
YNCHF | 2021-01-19T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 0 | lobbying_income | service_provided | [
"H.R. 6395/S. 4049 - National Defense Authorization Act for Fiscal Year 2021.",
"Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895."... | [
"DEF - Defense",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"IRENE BUENO",
"LISA GERMAN FOSTER",
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW"
] | [
35167,
38865,
38865,
35167,
69878
] | [
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/92901469-bc2b-4cd0-8ba1-05fc3d49c921/print/ | 92901469-bc2b-4cd0-8ba1-05fc3d49c921 | 92901469-bc2b-4cd0-8ba1-05fc3d49c921_76833_169120 | astellas pharma us, inc. | 2021-01-19T23:48:43 |
YNCHF | 2021-01-20T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical drugs"
] | [
"HCR - Health Issues"
] | [
"11 - Executive Office of the President (EOP)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN R RAY (Legislative Assistant, Rep. M... | [
42442,
51434,
53650,
60159,
67296,
68519,
139878
] | [
null,
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
"Legislative Director, Rep. Marsha Blackburn",
"Legislative Assistant, Rep. Mike Kelly",
null,
null
] | [
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/03c9c2ae-03f2-4c95-867e-86374297e1d8/print/ | 03c9c2ae-03f2-4c95-867e-86374297e1d8 | 03c9c2ae-03f2-4c95-867e-86374297e1d8_46038_153900 | astellas pharma us | 2021-01-20T22:01:21 |
YNCHF | 2021-01-20T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 0 | lobbying_income | service_provided | [
"Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP).\nASP, generally\nMedicare Part D, including removal ... | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR."
] | [
64580,
56477,
64580,
56477,
56477,
64580
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/a0a4d4ce-ee1a-4119-8251-5194ef9b35db/print/ | a0a4d4ce-ee1a-4119-8251-5194ef9b35db | a0a4d4ce-ee1a-4119-8251-5194ef9b35db_400762305_195037 | astellas pharma us, inc. | 2021-01-20T18:13:27 |
YNCHF | 2021-01-20T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 50,000 | lobbying_income | modify_service | [
"Issues related to Medicare Part D, including reforms, non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally",
"House and Senate Appropriations for FY 2021",
"Issues related to lobbying disclosure for US affiliates",
"Issues related to march-in rights under... | [
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations",
"LAW - Law Enforcement/Crime/Criminal Justice",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY"
] | [
64580,
56477,
56477,
64580,
56477,
64580,
64580,
56477
] | [
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/0abb3b37-58d8-4230-a397-28d6515c3db5/print/ | 0abb3b37-58d8-4230-a397-28d6515c3db5 | 0abb3b37-58d8-4230-a397-28d6515c3db5_400762305_195037 | astellas pharma us, inc. | 2021-01-20T18:23:05 |
YNCHF | 2021-01-21T00:00:00 | astellas pharma us, inc. | Pharmaceutical manufacturer. | 50,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid... | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2019-07-01 | null | IL | US | 1,007,033 | 0 | null | 2024-01-30T13:15:28.215474-05:00 | CAPITOL COUNSEL LLC | 700 13th Street NW, 2nd Floor, Washington, DC, 20005, US | 313,715 | Government affairs. | TRACEY A. GRAY | 39,384 | +1 202-861-3200 | [
"SHANNON FINLEY",
"ANN JABLON"
] | [
45351,
65069
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/184651/ | https://lda.senate.gov/api/v1/registrants/313715/ | https://lda.senate.gov/filings/public/filing/ffe4a0f7-82a5-4c2c-a4c2-446fee9aa21b/print/ | ffe4a0f7-82a5-4c2c-a4c2-446fee9aa21b | ffe4a0f7-82a5-4c2c-a4c2-446fee9aa21b_313715_184651 | astellas pharma us, inc. | 2021-01-21T00:56:14 |
YNCHF | 2021-01-21T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 60,000 | lobbying_income | modify_service | [
"Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform.",
"H.R. 6395/S. 4049 - National Defense Authorization Act for Fiscal Year 2021."
] | [
"HCR - Health Issues",
"DEF - Defense"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW",
"IRENE BUENO",
"LISA GERMAN FOSTER"
] | [
38865,
35167,
69878,
35167,
38865
] | [
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/91693666-9825-48b5-a936-d0c46d49adef/print/ | 91693666-9825-48b5-a936-d0c46d49adef | 91693666-9825-48b5-a936-d0c46d49adef_76833_169120 | astellas pharma us, inc. | 2021-01-21T23:25:24 |
YNCHF | 2021-01-21T00:00:00 | astellas pharma us, inc. | null | 450,000 | a | service_provided | [
"Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).",
"Value of Prescription Drugs, Senate & House. Issues related to Bayh-Dole Act (Pub. L. 96-517). Issues related to pharmaceutical supply chain management, S.3537 Protecting Our Pharmaceutical Suppl... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"VALARIE MOLAISON",
"VALARIE MOLAISON",
"VALARIE MOLAISON"
] | [
68274,
68274,
68274
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/128d4301-1f15-49be-98b1-1ac75301a3f0/print/ | 128d4301-1f15-49be-98b1-1ac75301a3f0 | 128d4301-1f15-49be-98b1-1ac75301a3f0_40032268_188248 | astellas pharma us, inc. | 2021-01-21T23:49:51 |
YNCHF | 2021-04-19T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"General issues pertaining to the cost of prescription drugs; general issues related to drug research and innovation. American Rescue Plan, provision pertaining to cap of Average Manufacturer Prices (AMP)."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q1 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/35e05b54-254b-409e-b71d-181dc11fb2e6/print/ | 35e05b54-254b-409e-b71d-181dc11fb2e6 | 35e05b54-254b-409e-b71d-181dc11fb2e6_305054_181397 | astellas pharma us, inc. | 2021-04-19T18:06:46 |
YNCHF | 2021-04-19T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 60,000 | lobbying_income | service_provided | [
"Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally\nIssues related to biopharmaceutical supply chain, generally",
"Issues related to Medicare Part D, including reforms, non-interference, rebate policy issues\nIssues related to drug pric... | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q1 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY"
] | [
64580,
56477,
64580,
56477
] | [
null,
null,
null,
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/b591433f-1e53-4640-bd80-2aa405ba4cba/print/ | b591433f-1e53-4640-bd80-2aa405ba4cba | b591433f-1e53-4640-bd80-2aa405ba4cba_400762305_195037 | astellas pharma us, inc. | 2021-04-19T20:00:41 |
YNCHF | 2021-04-20T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical drugs"
] | [
"HCR - Health Issues"
] | [
"11 - Executive Office of the President (EOP)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q1 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)",
"KENNETH LEE HODGE",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN R RAY (Legisl... | [
42442,
51434,
53650,
139878,
60159,
67296,
68519
] | [
null,
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null,
"Legislative Director, Rep. Marsha Blackburn",
"Legislative Assistant, Rep. Mike Kelly",
null
] | [
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/aa3b5b2d-862e-4268-a130-2643b75496df/print/ | aa3b5b2d-862e-4268-a130-2643b75496df | aa3b5b2d-862e-4268-a130-2643b75496df_46038_153900 | astellas pharma us | 2021-04-21T00:19:29 |
YNCHF | 2021-04-20T00:00:00 | astellas pharma us, inc. | Pharmaceutical manufacturer. | 50,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2)."
] | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q1 | 2019-07-01 | null | IL | US | 1,007,033 | 0 | null | 2024-01-30T13:15:28.215474-05:00 | CAPITOL COUNSEL LLC | 700 13th Street NW, 2nd Floor, Washington, DC, 20005, US | 313,715 | Government affairs. | TRACEY A. GRAY | 39,384 | +1 202-861-3200 | [
"SHANNON FINLEY",
"ANN JABLON"
] | [
45351,
65069
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/184651/ | https://lda.senate.gov/api/v1/registrants/313715/ | https://lda.senate.gov/filings/public/filing/b5238faf-0253-4e6d-b91c-eb34abe3ae3b/print/ | b5238faf-0253-4e6d-b91c-eb34abe3ae3b | b5238faf-0253-4e6d-b91c-eb34abe3ae3b_313715_184651 | astellas pharma us, inc. | 2021-04-20T19:34:00 |
YNCHF | 2021-04-20T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 60,000 | lobbying_income | service_provided | [
"Issues related to drug innovation; value of prescription drugs;\nIssues related to march in rights under the Bayh-Dole Act 96-517; \nIssues related to Medicare Part D redesign and reform;\nIssues related to prostate cancer screening; \nRemoval of AMP Cap."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q1 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW",
"BRADY KING (Chief of Staff, Rep Kendra Horn; Chief of Staff, Sen Roland Burris; Chief of Staff, Rep Tim Mahoney; LD, Rep Allen Boyd; National Security Advisor, Sen Edward Kennedy; National Security Advisor, Sen Mark Dayton; Approps Associate, Rep Chet Edw... | [
38865,
35167,
69878,
107387
] | [
null,
null,
null,
"Chief of Staff, Rep Kendra Horn; Chief of Staff, Sen Roland Burris; Chief of Staff, Rep Tim Mahoney; LD, Rep Allen Boyd; National Security Advisor, Sen Edward Kennedy; National Security Advisor, Sen Mark Dayton; Approps Associate, Rep Chet Edwards"
] | [
false,
false,
false,
true
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/44569bd4-f2a1-4c91-be12-0af5f658226e/print/ | 44569bd4-f2a1-4c91-be12-0af5f658226e | 44569bd4-f2a1-4c91-be12-0af5f658226e_76833_169120 | astellas pharma us, inc. | 2021-04-20T22:32:42 |
YNCHF | 2021-04-20T00:00:00 | astellas pharma us, inc. | null | 450,000 | a | service_provided | [
"Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).",
"Value of Prescription Drugs, Senate & House. Issues related to Bayh-Dole Act (Pub.L.96-517). Issues related to pharmaceutical supply chain management, S.3537 Protecting Out Pharmaceutical Supply ... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q1 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"VALARIE MOLAISON",
"JONATHAN OEHMEN (Legislative Correspondent, Legislative Asst., and Sr. Legislative Asst. for Rep. John Sullivan (OK Dist. 1); Legislative Director and then Chief of Staff for Rep. Bill Flores (TX Dist. 17))",
"VALARIE MOLAISON",
"JONATHAN OEHMEN (Legislative Correspondent, Legislative Ass... | [
68274,
107392,
68274,
107392,
68274,
99438,
107392
] | [
null,
"Legislative Correspondent, Legislative Asst., and Sr. Legislative Asst. for Rep. John Sullivan (OK Dist. 1); Legislative Director and then Chief of Staff for Rep. Bill Flores (TX Dist. 17)",
null,
"Legislative Correspondent, Legislative Asst., and Sr. Legislative Asst. for Rep. John Sullivan (OK Dist. ... | [
false,
true,
false,
true,
false,
true,
true
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/b5dbd8b8-373d-48fd-90b0-4f19bac1aced/print/ | b5dbd8b8-373d-48fd-90b0-4f19bac1aced | b5dbd8b8-373d-48fd-90b0-4f19bac1aced_40032268_188248 | astellas pharma us, inc. | 2021-04-21T01:42:40 |
YNCHF | 2021-07-19T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"General issues pertaining to the cost of prescription drugs; general issues related to drug research and innovation; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q2 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/e840d959-48c0-4c50-a07d-6a5e4b9665ab/print/ | e840d959-48c0-4c50-a07d-6a5e4b9665ab | e840d959-48c0-4c50-a07d-6a5e4b9665ab_305054_181397 | astellas pharma us, inc. | 2021-07-19T17:54:06 |
YNCHF | 2021-07-19T00:00:00 | astellas pharma us, inc. | Pharmaceutical product manufacturer | 60,000 | lobbying_income | service_provided | [
"Issues related to drug innovation; \nValue of prescription drugs;\nIssues related to march in rights under the Bayh-Dole Act 96-517; \nIssues related to prostate cancer screening; \nH.R. 3.",
"Removal of AMP Cap;\nIssues related to Medicare Part D redesign and reform."
] | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q2 | 2019-02-01 | null | IL | US | 1,002,855 | 0 | null | 2024-01-25T16:57:50.222685-05:00 | NVG, LLC | 1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US | 76,833 | Government Relations Firm | KATE SCHUMACHER | 35,960 | +1 202-540-1070 | [
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW",
"BRADY KING",
"LISA GERMAN FOSTER",
"IRENE BUENO",
"EDEN SHIFERAW",
"BRADY KING"
] | [
38865,
35167,
69878,
107387,
38865,
35167,
69878,
107387
] | [
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/169120/ | https://lda.senate.gov/api/v1/registrants/76833/ | https://lda.senate.gov/filings/public/filing/b86c0fa3-7cc0-4f00-92ec-b0817b596c93/print/ | b86c0fa3-7cc0-4f00-92ec-b0817b596c93 | b86c0fa3-7cc0-4f00-92ec-b0817b596c93_76833_169120 | astellas pharma us, inc. | 2021-07-19T20:05:53 |
YNCHF | 2021-07-20T00:00:00 | astellas pharma us, inc. | pharmaceutical company | 60,000 | lobbying_income | service_provided | [
"Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally\nIssues related to biopharmaceutical supply chain, generally",
"Issues related to Medicare Part D, including reforms, non-interference, rebate policy issues\nIssues related to drug pric... | [
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q2 | 2012-01-01 | null | IL | US | 125 | 0 | 0 | 2024-04-22T11:03:08.110623-04:00 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 900 G Street NW, Suite 301, Washington, DC, 20001, US | 400,762,305 | Lobbying Firm | VINCENT ROBERTI | 400,762,305 | +1 202-846-8185 | [
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY",
"VINCENT A. ROBERTI, SR.",
"STEVEN E IRIZARRY"
] | [
64580,
56477,
64580,
56477
] | [
null,
null,
null,
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/195037/ | https://lda.senate.gov/api/v1/registrants/400762305/ | https://lda.senate.gov/filings/public/filing/55091067-507b-45d7-b10d-fb233809e796/print/ | 55091067-507b-45d7-b10d-fb233809e796 | 55091067-507b-45d7-b10d-fb233809e796_400762305_195037 | astellas pharma us, inc. | 2021-07-20T16:59:04 |
YNCHF | 2021-07-20T00:00:00 | astellas pharma us, inc. | Pharmaceutical manufacturer. | 50,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D and prescription drug pricing, including related provisions in H.R. 3, the Lower Drug Costs Now Act, and H.R. 19, the Lower Costs, More Cures Act.\n\nCoronavirus response efforts, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2... | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q2 | 2019-07-01 | null | IL | US | 1,007,033 | 0 | null | 2024-01-30T13:15:28.215474-05:00 | CAPITOL COUNSEL LLC | 700 13th Street NW, 2nd Floor, Washington, DC, 20005, US | 313,715 | Government affairs. | TRACEY A. GRAY | 39,384 | +1 202-861-3200 | [
"SHANNON FINLEY",
"ANN JABLON"
] | [
45351,
65069
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/184651/ | https://lda.senate.gov/api/v1/registrants/313715/ | https://lda.senate.gov/filings/public/filing/538400e4-cef7-41a4-a170-440bf555fc71/print/ | 538400e4-cef7-41a4-a170-440bf555fc71 | 538400e4-cef7-41a4-a170-440bf555fc71_313715_184651 | astellas pharma us, inc. | 2021-07-20T18:33:37 |
YNCHF | 2021-07-20T00:00:00 | astellas pharma us, inc. | null | 450,000 | a | service_provided | [
"Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).",
"Value of Prescription Drugs, Senate & House. Issues related to Bayh-Dole Act (Pub.L.96-517).",
"Issues related to Medicare Part D policies, including patient access, non-interference and rebate... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q2 | 2018-05-17 | null | IL | US | 12 | 0 | 1 | 2024-01-24T11:02:27.018268-05:00 | ASTELLAS PHARMA US, INC. | 2375 Waterview Drive, Northbrook, IL, 60062, US | 40,032,268 | Pharmaceuticals | CHRISTINE BLOOMQUIST | 39,903 | +1 571-471-9064 | [
"JONATHAN OEHMEN",
"JONATHAN OEHMEN",
"JAMES ROLLINS",
"JONATHAN OEHMEN"
] | [
107392,
107392,
99438,
107392
] | [
null,
null,
null,
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/188248/ | https://lda.senate.gov/api/v1/registrants/40032268/ | https://lda.senate.gov/filings/public/filing/edda3861-3702-4442-b66a-8617215a3d91/print/ | edda3861-3702-4442-b66a-8617215a3d91 | edda3861-3702-4442-b66a-8617215a3d91_40032268_188248 | astellas pharma us, inc. | 2021-07-21T00:54:56 |
YNCHF | 2021-07-22T00:00:00 | astellas pharma us | Pharmaceutical company | 40,000 | lobbying_income | service_provided | [
"Issues related to pharmaceutical drugs"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q2 | 2018-01-01 | null | IL | US | 583 | 0 | null | 2024-04-19T19:01:33.063682-04:00 | JEFFREY J. KIMBELL AND ASSOCIATES | 401 9th Street NW, Suite 920, Washington, DC, 20004, US | 46,038 | Consulting Firm | JEFFREY KIMBELL | 34,381 | +1 202-735-2590 | [
"JEFFREY J KIMBELL",
"JODIE LOCKHART",
"KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)",
"JOHN R RAY (Legislative Assistant, Rep. Mike Kelly)",
"DAVID RUDLOFF",
"JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Execu... | [
42442,
51434,
60159,
67296,
68519,
53650,
139878
] | [
null,
null,
"Legislative Director, Rep. Marsha Blackburn",
"Legislative Assistant, Rep. Mike Kelly",
null,
"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President",
null
] | [
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/153900/ | https://lda.senate.gov/api/v1/registrants/46038/ | https://lda.senate.gov/filings/public/filing/4d9a3f89-bef1-4d36-ba98-9887b13d2dff/print/ | 4d9a3f89-bef1-4d36-ba98-9887b13d2dff | 4d9a3f89-bef1-4d36-ba98-9887b13d2dff_46038_153900 | astellas pharma us | 2021-07-22T17:13:21 |
YNCHF | 2021-10-16T00:00:00 | astellas pharma us, inc. | Pharmaceutical manufacturer. | 50,000 | lobbying_income | service_provided | [
"Issues related to Medicare Part D and prescription drug pricing, including related provisions in the Build Back Better Act, Budget Reconciliation Legislative Recommendations Relating to Drug Pricing, including provisions regarding Fair Drug Price Negotiation and Prescription Drug Inflation Rebates, in Subtitle E, ... | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q3 | 2019-07-01 | null | IL | US | 1,007,033 | 0 | null | 2024-01-30T13:15:28.215474-05:00 | CAPITOL COUNSEL LLC | 700 13th Street NW, 2nd Floor, Washington, DC, 20005, US | 313,715 | Government affairs. | TRACEY A. GRAY | 39,384 | +1 202-861-3200 | [
"SHANNON FINLEY",
"ANN JABLON"
] | [
45351,
65069
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/184651/ | https://lda.senate.gov/api/v1/registrants/313715/ | https://lda.senate.gov/filings/public/filing/224e27ce-5835-4469-b1e9-a4d78eef8537/print/ | 224e27ce-5835-4469-b1e9-a4d78eef8537 | 224e27ce-5835-4469-b1e9-a4d78eef8537_313715_184651 | astellas pharma us, inc. | 2021-10-16T19:19:40 |
YNCHF | 2021-10-18T00:00:00 | astellas pharma us, inc. | Pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"H.R. 3684, Infrastructure, Investments and Jobs Act, healthcare provisions; H.R. 5376, Build Back Better Act, drug pricing provisions; H.R. 5237, Reduced Costs and Continued Cures Act; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; general issues related to drug research and innovation."
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q3 | 2014-11-01 | null | IL | US | 1,004,265 | 0 | null | 2024-01-30T13:11:27.932595-05:00 | PORTERFIELD, FETTIG & SEARS, LLC | 400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US | 305,054 | government affairs | DAWN SEARS | 38,091 | +1 202-715-0845 | [
"JEREMY RABINOVITZ"
] | [
61187
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/181397/ | https://lda.senate.gov/api/v1/registrants/305054/ | https://lda.senate.gov/filings/public/filing/634023b1-6031-4da3-928a-7bee27c17d5f/print/ | 634023b1-6031-4da3-928a-7bee27c17d5f | 634023b1-6031-4da3-928a-7bee27c17d5f_305054_181397 | astellas pharma us, inc. | 2021-10-18T16:04:01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.